antiaging
George Church believes that enhancing human intelligence will stay ahead of artificial synthetic intelligence. George Church is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and MIT. He is Director of the …
Harvard researchers identified several small molecules that appear to reverse cellular aging in premature aging disease. Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells (Cell Stem Cell Journal) High-throughput screening identified specific small-molecule PAPD5 inhibitor BCH001  …
Young blood plasma is known to confer beneficial effects on various organs in mice. However, it was not known whether young plasma rejuvenates cells and tissues at the epigenetic level; whether it alters the epigenetic clock, which is a highly-accurate …
The Coronavirus Pandemic is reshaping our current world and it is reshaping the future. The pandemic and global lockdown is causing a global economic depression, shattering the energy markets and killing previously might companies and industries. 18 months ago, Nextbigfuture …
Transient reprogramming, mediated by transient expression of mRNAs, promotes a rapid reversal of both cellular aging and of epigenetic clock in human fibroblasts and endothelial cells, reduces the inflammatory profile in human chondrocytes, and restores youthful regenerative response to aged, …
After Shock is a collection of essays by Futurists. It is published in 2020 which is the 50 year anniversary of Alvin Toffler’s Future Shock book. There are many essays reviewing and framing the key developments of the internet, social …
Global Venture capital for 2018 and 2019 has been about $200-250 billion. US Venture capital reached $130 billion. This surpassed the level in 2000 when it was $100 billion. There is $9-10 billion per year funding Artificial Intelligence and $5.8 …
There are a few dozen antiaging rejuvenation treatments that are progressing through pre-clinical and clinical trials. Lifespan.io is tracking the antiaging rejuvenation treatments on a rejuvenation roadmap. Two treatments are in phase 3 clinical trial. Samumed is developing drugs for …
When futurists predict that technology X will be developed, there is a common reply from people who do not know the history of technology. The replies are variations of “Technology X will be developed after we solve Y”. Y can …
Underdog Pharma is developing disease-modifying treatments for atherosclerosis and other age-related diseases. They want to prevent or reverse atherosclerosis by removing a harmful lipid known as 7-ketocholesterol (7KC) from the arterial walls. Underdog has a molecule that can extract the …